Skip to main content

Bayer A G Ord(BAYZF)
OTC US

Today's Change
Delayed Last Update
Day Low42.0000
Day High42.5300
Open:42.5300
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Bayer A G Ord

Select a category then submit the form to load news
Bayer Supervisory Board Member Buys Shares in Disclosed Manager Transaction
Bayer (0P6S) Receives a Hold from Deutsche Bank
Kepler Capital Reaffirms Their Buy Rating on Bayer (0P6S)
Bayer (0P6S) Gets a Hold from Berenberg Bank
Jefferies Remains a Hold on Bayer (0P6S)
Goldman Sachs Remains a Buy on Bayer (0P6S)
J.P. Morgan Sticks to Its Buy Rating for Bayer (0P6S)
Bayer (0P6S) Receives a Buy from Barclays
UBS Sticks to Their Hold Rating for Bayer (0P6S)
Kepler Capital Sticks to Their Buy Rating for Bayer (0P6S)
Bayer (0P6S) Receives a Buy from Goldman Sachs
DZ BANK AG downgrades Bayer (0P6S) to a Sell
Bayer (0P6S) Receives a Hold from UBS
Kepler Capital Keeps Their Buy Rating on Bayer (0P6S)
UBS Remains a Hold on Bayer (0P6S)
Goldman Sachs Reaffirms Their Buy Rating on Bayer (0P6S)
J.P. Morgan Reaffirms Their Buy Rating on Bayer (0P6S)
Bayer (0P6S) Receives a Buy from Barclays
Bayer (0P6S) Gets a Buy from J.P. Morgan
Goldman Sachs Sticks to Its Buy Rating for Bayer (0P6S)
Kepler Capital Remains a Buy on Bayer (0P6S)
J.P. Morgan Reaffirms Their Buy Rating on Bayer (0P6S)
Kepler Capital Remains a Buy on Bayer (0P6S)
UBS Keeps Their Hold Rating on Bayer (0P6S)
Barclays Sticks to Its Buy Rating for Bayer (0P6S)
Berenberg Bank Reaffirms Their Hold Rating on Bayer (BAYRY)
DZ BANK AG Sticks to Its Buy Rating for Bayer (0P6S)
Goldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)
Jefferies Sticks to Their Hold Rating for Bayer (0P6S)
J.P. Morgan Keeps Their Buy Rating on Bayer (0P6S)
UBS Reaffirms Their Hold Rating on Bayer (0P6S)
Berenberg Bank Sticks to Their Hold Rating for Bayer (BAYRY)

Profile

Bayer AG is an international research-based company active in life sciences, polymers, and chemicals. Bayer's operating units include health-care products, material sciences, and crop sciences. Bayer's over-the-counter health-care product division is the third-largest in the world. HealthCare subgroup is divided into two reporting segments: Pharmaceuticals and Consumer Health. The Pharmaceuticals segment focuses on prescription products, especially for women's healthcare and cardiology and also on specialty therapeutics in the fields of oncology, hematology and ophthalmology. Its Consumer Health segment includes the Consumer Care, Medical Care and Animal Health divisions. It mainly focus on non-prescription medicines, dietary supplements and dermatology products. Crop Science has businesses in seeds, crop protection and non-agricultural pest control. Crop science businesss has two operating segments: Crop Protection / Seeds and Environmental Science. Crop Protection / Seeds markets a portfolio of high-value seeds and traits along with chemical and biological pest management solutions, at the same time providing extensive customer service to the agriculture industry. Environmental Science focuses on non-agricultural applications, with a broad portfolio of pest control products and services for areas ranging from the home and garden sector to forestry. The Material Science unit develops, manufactures and markets high-tech polymer materials including polyurethane raw materials, polycarbonates, coating and adhesive raw materials and functional films. This subgroup also manufactures and markets selected inorganic basic chemicals. Material Science is organized into the Polyurethanes, Polycarbonates, and Coatings, Adhesives, Specialties business units, and the Industrial Operations area.